The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Abernethy Matt since year 2005.
The trader's CIK number is 1724097.
At the time of the last reporting, Abernethy Matt was the Chief Financial Officer of Neurocrine Biosciences Inc .
(stock ticker symbol NBIX).
See this page for all insider trading activities at Neurocrine Biosciences Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2020-02-07||NBIX||Neurocrine Biosciences Inc||Sale||2,030||103.35||209,806|
|2019-12-02||NBIX||Neurocrine Biosciences Inc||Sale||1,645||116.33||191,361|
|2018-12-03||NBIX||Neurocrine Biosciences Inc||Sale||1,178||90.00||106,020|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Abernethy Matt (Chief Financial Officer of Neurocrine Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.